In national news:

A unit of Insys Therapeutics Inc pleaded guilty on Friday to fraud charges as part of an $225 million deal with the U.S. Justice Department resolving claims that the drugmaker bribed doctors to prescribe an addictive opioid medication. The former CEO of the company was found guilty of racketeering along with four others last month.

Read more from Reuters here.

Leave a Comment

Your email address will not be published. Required fields are marked *